SCHEMBL2177849

SCHEMBL2177849

C[S+]([O-])CC(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9641013 1.00
SCHEMBL9640216 1.00
SCHEMBL8153060 0.78 TDP1 (0.32)
SCHEMBL454918 0.75
SCHEMBL4442753 0.75
SCHEMBL9635466 0.73
SCHEMBL1286839 0.73 LMNA (0.35)
SCHEMBL2476307 0.73
Potassium Ion SCHEMBL11581788 0.73
SCHEMBL4465736 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110128376-B Compound, preparation method and application of compound as latent epoxy curing agent 万华化学集团股份有限公司 2020-11-20 CN claimed
US-20260069549-A1 COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS MODERNATX INC (US) 2026-03-12 US disclosed
EP-4186888-B1 COMPOUND AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS MODERNATX INC (US) 2025-11-26 EP disclosed
US-20250228777-A1 COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS ARES CAPITAL CORPORATION, AS AGENT 2025-07-17 US disclosed
US-12324859-B2 Compounds and compositions for intracellular delivery of therapeutic agents MODERNATX, INC. (US) 2025-06-10 US disclosed
US-12263248-B2 Compounds and compositions for intracellular delivery of therapeutic agents MODERNATX, INC. (US) 2025-04-01 US disclosed
EP-4186888-A1 COMPOUND AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS ModernaTX, Inc. (US) 2023-05-31 EP disclosed
US-20220409536-A1 COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS ARES CAPITAL CORPORATION, AS AGENT 2022-12-29 US disclosed
EP-3596041-B1 COMPOUND AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS MODERNATX INC (US) 2022-11-02 EP disclosed
US-20220340893-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION A/S (DK) 2022-10-27 US disclosed
EP-0513030-A1 NEW CIS-PLATINUM COMPLEXES WITH CHELATING AMINES AND SULPHINYL CARBOXYLATES. BOEHRINGER MANNHEIM ITALIA (IT) 1992-11-19 EP disclosed
EP-0287042-B1 2-SULPHINYL-ACETYL-1,3-THIAZOLIDINES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS BOEHRINGER MANNHEIM ITALIA S.P.A. (IT) 1992-09-16 EP disclosed
WO-1991011450-A1 NEW CIS-PLATINUM COMPLEXES WITH CHELATING AMINES AND SULPHINYL CARBOXYLATES BOEHRINGER MANNHEIM ITALIA S.P.A. (IT) 1991-08-08 WO disclosed
US-4849437-A 2-sulphinyl-acetyl-1,3-thiazolidines, their preparation and pharmaceutical compositions BOEHRINGER BIOCHEMIA ROBIN S.P.A. (IT) 1989-07-18 US disclosed
EP-0287042-A1 2-Sulphinyl-acetyl-1,3-thiazolidines, their preparation and pharmaceutical compositions BOEHRINGER MANNHEIM ITALIA S.P.A. (IT) 1988-10-19 EP disclosed
US-4595532-A N-(substituted-methyl)-azetidin-2-ones UNIVERSITY OF NOTRE DAME DU LAC (US) 1986-06-17 US disclosed
EP-0116432-A2 Improvements in or relating to N-(substituted-methyl)-azetidin-2-ones THE UNIVERSITY OF NOTRE DAME DU LAC (US) 1984-08-22 EP disclosed
US-4229573-A BACTERICIDES ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) 1980-10-21 US disclosed
US-4101657-A Cephamycins as antibacterial agents SMITHKLINE CORPORATION (US) 1978-07-18 US disclosed
US-4059578-A ANTIBACTERIAL SMITHKLINE CORPORATION (US) 1977-11-22 US disclosed